表观遗传/生物钟与多囊卵巢综合征
本文综述表观遗传改变和生物钟基因修饰在多囊卵巢综合征(PCOS)发病中的作用。PCOS影响6-20%育龄女性,遗传易感位点仅解释约10%遗传度。DNA甲基化、组蛋白修饰和非编码RNA改变见于PCOS相关疾病及患者外周血单核细胞、脂肪组织、颗粒细胞和肝脏,患者基因组整体低甲基化。睡眠障碍和生物钟基因表达紊乱亦被观察到。表观遗传改变作为诊断标志物面临区分因果的挑战,靶向表观遗传修饰可能为精准医学开辟途径,但尚缺乏大型特征明确队列数据。
要点
- PCOS影响6-20%育龄女性,遗传位点仅解释约10%遗传度。
- PCOS患者基因组整体低甲基化,特定基因甲基化改变涉及激素调节和炎症通路。
- 睡眠障碍和生物钟基因表达紊乱见于PCOS患者外周血单核细胞或颗粒细胞。
核心结论
- 理解遗传学、表观遗传学和生物钟节律之间的相互作用,可能为未来PCOS的早期诊断和治疗策略提供有价值的信息。
研究设计与样本
- 综述,探讨表观遗传改变和生物钟基因修饰作为PCOS发病机制潜在因素的作用。
主要发现
- PCOS影响6-20%育龄女性,与代谢综合征、2型糖尿病、心血管疾病、情绪障碍、子宫内膜癌和非酒精性脂肪性肝病风险增加相关。
- 遗传研究发现的易感位点约解释10%的PCOS遗传度。
- DNA甲基化、组蛋白修饰和非编码RNA改变已在糖尿病、心血管疾病和肥胖等PCOS相关疾病中被描述。
- 多种动物模型显示产前暴露于雄激素或抗苗勒管激素与后续世代PCOS样表型相关,提示PCOS存在表观遗传编程。
- 在人类中,PCOS患者的外周血单核细胞、脂肪组织、颗粒细胞和肝脏已报告表观遗传改变;与健康对照相比,PCOS患者基因组整体低甲基化,不同组织中报告了特定的低甲基化或高甲基化基因,主要涉及激素调节和炎症通路以及脂质和葡萄糖代谢。
临床怎么用
- 表观遗传改变作为诊断生物标志物具有前景,但当前挑战在于区分这些改变是PCOS的原因还是结果。
- 靶向表观遗传修饰可能为PCOS的精准医学开辟途径,包括生活方式干预和药物治疗。
局限性
- 目前仍缺乏大型、特征明确的PCOS表型队列数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Polycystic ovary syndrome (PCOS) affects 6-20% of reproductive-aged women. It is associated with increased risks of metabolic syndrome, Type 2 diabetes, cardiovascular diseases, mood disorders, endometrial cancer and non-alcoholic fatty liver disease. Although various susceptibility loci have been identified through genetic studies, they account for ∼10% of PCOS heritability. Therefore, the etiology of PCOS remains unclear. This review explores the role of epigenetic changes and modifications in circadian clock genes as potential contributors to PCOS pathogenesis. Epigenetic alterations, such as DNA methylation, histone modifications, and non-coding RNA changes, have been described in diseases related to PCOS, such as diabetes, cardiovascular diseases, and obesity. Furthermore, several animal models have illustrated a link between prenatal exposure to androgens or anti-Müllerian hormone and PCOS-like phenotypes in subsequent generations, illustrating an epigenetic programming in PCOS. In humans, epigenetic changes have been reported in peripheral blood mononuclear cells (PBMC), adipose tissue, granulosa cells (GC), and liver from women with PCOS. The genome of women with PCOS is globally hypomethylated compared to healthy controls. However, specific hypomethylated or hypermethylated genes have been reported in the different tissues of these women. They are mainly involved in hormonal regulation and inflammatory pathways, as well as lipid and glucose metabolism. Additionally, sleep disorders are present in women with PCOS and disruptions in clock genes' expression patterns have been observed in their PBMC or GCs. While epigenetic changes hold promise as diagnostic biomarkers, the current challenge lies in distinguishing whether these changes are causes or consequences of PCOS. Targeting epigenetic modifications potentially opens avenues for precision medicine in PCOS, including lifestyle interventions and drug therapies. However, data are still lacking in large cohorts of well-characterized PCOS phenotypes. In conclusion, understanding the interplay between genetics, epigenetics, and circadian rhythms may provide valuable insights for early diagnosis and therapeutic strategies in PCOS in the future.
引用
- Vatier C, Christin-Maitre S. Epigenetic/circadian clocks and PCOS. Hum Reprod. 2024. PMID: 38600622. doi:10.1093/humrep/deae066
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。